Literature DB >> 22274304

[Unusual skin alterations in a 72-year-old patient with multiple myeloma].

C Hart1, S Wurm, C Hafner, R Andreesen, M Grube.   

Abstract

We report on a 72-year-old female patient with multiple myeloma who presented with alopecia and eye-catching alterations of the skin and the nails. A biopsy of the skin could confirm the diagnosis of immunoglobulin light chain (AL) amyloidosis, which was also suspected of having affected other organs. After six cycles of a cytoreductive therapy with bortezomib and dexamethasone a very good partial response of the multiple myeloma was seen and an improvement in the skin and nail alterations could be achieved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274304     DOI: 10.1007/s00108-011-2996-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

Review 1.  An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.

Authors:  Vaishali Sanchorawala; David C Seldin
Journal:  Amyloid       Date:  2007-12       Impact factor: 7.141

2.  Familial myeloma.

Authors:  Nicola J Camp; Theresa L Werner; Lisa A Cannon-Albright
Journal:  N Engl J Med       Date:  2008-10-16       Impact factor: 91.245

Review 3.  Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.

Authors:  Adam D Cohen; Raymond L Comenzo
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

4.  Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.

Authors:  Giovanni Palladini; Robert A Kyle; Dirk R Larson; Terry M Therneau; Giampaolo Merlini; Morie A Gertz
Journal:  Amyloid       Date:  2005-06       Impact factor: 7.141

5.  Congo red as a stain for fluorescence microscopy of amyloid.

Authors:  H Puchtler; F Sweat
Journal:  J Histochem Cytochem       Date:  1965 Nov-Dec       Impact factor: 2.479

6.  Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis.

Authors:  M A Duston; M Skinner; R F Meenan; A S Cohen
Journal:  Arthritis Rheum       Date:  1989-01

7.  Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Authors:  Meletios Dimopoulos; Robert Kyle; Jean-Paul Fermand; S Vincent Rajkumar; Jesus San Miguel; Asher Chanan-Khan; Heinz Ludwig; Douglas Joshua; Jayesh Mehta; Morie Gertz; Hervé Avet-Loiseau; Meral Beksaç; Kenneth C Anderson; Philippe Moreau; Seema Singhal; Hartmut Goldschmidt; Mario Boccadoro; Shaji Kumar; Sergio Giralt; Nikhil C Munshi; Sundar Jagannath
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

8.  Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis.

Authors:  W Lamm; W Willenbacher; A Lang; N Zojer; E Müldür; H Ludwig; B Schauer-Stalzer; C C Zielinski; J Drach
Journal:  Ann Hematol       Date:  2010-09-07       Impact factor: 3.673

9.  Nail dystrophy and blisters as sole manifestations in myeloma-associated amyloidosis.

Authors:  Yasuyuki Fujita; Yukiko Tsuji-Abe; Kazuko C Sato-Matsumura; Masashi Akiyama; Hiroshi Shimizu
Journal:  J Am Acad Dermatol       Date:  2006-04       Impact factor: 11.527

Review 10.  Amyloidosis and the lung.

Authors:  H J Lachmann; P N Hawkins
Journal:  Chron Respir Dis       Date:  2006       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.